5 Pharma Stocks to Buy According to Mark Lampert’s Biotechnology Value Fund

3. Olema Pharmaceuticals, Inc. (NASDAQ:OLMA

Biotechnology Value Fund’s Stake Value: $186million

Percentage of Biotechnology Value Fund’s 13F Portfolio: 6.99% 

Number of Hedge Fund Holders: 17

San Francisco-based Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) is the third-largest stock holding of Mark Lampert’s Biotechnology Value fund, according to the June quarter filings. The fund first initiated a position in Olema during the final quarter of last year and left its position unchanged in the second quarter of 2021.